Browsing College of Medicine and Health by Author "Napier, M"
|1 July 2017||The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation. ||Huxley, N; Crathorne, L; Varley-Campbell, J; et al.|
|1 March 2018||Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England. ||Tikhonova, IA; Huxley, N; Snowsill, T; et al.|
|1 September 2018||Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis ||Mujica-Mota, R; Varley-Campbell, J; Tikhonova, I; et al.|